PhD or Masters or Honours

Hepatitis B virus (HBV) is the leading cause of primary liver cancer worldwide, although the mechanisms are unclear. Viral mutations and host immune responses are thought to drive development of cancer. We have developed HBV replicons containing key mutations, which we will use to study the mechanisms of HBV-induced liver cancer in cell culture models.

Supervisor: Dr. Mark Douglas, mark.douglas@sydney.edu.au